Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$12.42 – $18.00
36% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $346.53B | $305.82B | $318.35B | $352.25B | $398.37B | $442.23B | $495.56B | $497.26B |
| Cost of revenue | $119.34B | $79.62B | $80.44B | $87.85B | $86.92B | $111.21B | $132.61B | $128.05B |
| Gross profit | $227.19B | $226.20B | $237.91B | $264.40B | $311.46B | $331.03B | $362.95B | $369.21B |
| Gross margin | 65.6% | 74.0% | 74.7% | 75.1% | 78.2% | 74.9% | 73.2% | 74.2% |
| R&D | $48.59B | $53.51B | $52.31B | $57.68B | $62.90B | $81.51B | $103.54B | $101.27B |
| Operating income | $75.03B | $45.80B | $58.99B | $61.17B | $82.37B | $86.44B | $91.87B | $102.36B |
| EBITDA | $84.47B | $64.60B | $74.71B | $79.86B | $87.14B | $113.03B | $115.77B | $116.32B |
| Net income | $54.41B | $67.08B | $47.03B | $52.35B | $53.57B | $81.19B | $59.87B | $67.10B |
| Net margin | 15.7% | 21.9% | 14.8% | 14.9% | 13.4% | 18.4% | 12.1% | 13.5% |
| EPS (diluted) | 100.95 | 124.46 | 87.50 | 97.39 | 99.66 | 151.01 | 113.06 | 128.18 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $527.7B | $154.17 | $149.43–$159.50 | 1 |
| 2027 | $537.1B | $179.15 | $173.64–$185.35 | 1 |
| 2028 | $542.6B | $174.06 | $168.71–$180.08 | 2 |
| 2029 | $560.5B | $174.14 | $168.78–$180.16 | 1 |
Forward consensus · source: Financial Modeling Prep
KYOWA HAKKO KOGYO
No one on the platform currently holds KYKOF.
No tracked institution reports a position in KYKOF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-12-31 | $35.0000 | |
| 2026-06-30 | $35.0000 | |
| 2025-12-31 | $32.0000 | 2026-03-23 |
| 2025-06-30 | $30.0000 | 2025-09-01 |
| 2024-12-31 | $29.0000 | 2025-03-21 |
| 2024-06-28 | $29.0000 | 2024-09-02 |
| 2023-12-29 | $29.0000 | 2024-03-25 |
No one on the platform has traded KYKOF yet.
| $8.7B |
| — |
| MSMKFMatsukiyoCocokara & Co. | $14.60 | +0.00% | $5.7B | — |
| OPHLFOno Pharmaceutical Co., Ltd. | $13.50 | +0.00% | $6.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.1× earnings vs its 0.1× historical median P/E.
Fair value ≈ $13.57 · price $14.43 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.